MedTrace Logo

Edessy Stem Cell Score (ESS), Endometrium, Endometrioma

NCT02103452 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2014-04-04

No results posted yet for this study

Summary

Purpose of this study is to evaluate stem cell expression (SCE) in endometriotic (E) and non endometriotic ovarian and endometrial tissues.

Conditions

  • Endometriosis, Ovarian

Interventions

PROCEDURE

Ovarian and endometrial samples

Ovarian and endometrial samples were evaluated by hematoxlin \&eosin for histopathology (HP) and of oct-4 for immunohistochemistry (IH) for SCE

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Principal Investigators

  • Mahmoud Edessy, MD · Al-Azhar University

  • Hala hosni, MD · Cairo University

  • Magdy Olama, MD · Al-Azhar University

  • Mohammad A Sattar, MD · Al-Azhar University

  • Ahmad Monir, MSc · Al-Azhar University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02103452 on ClinicalTrials.gov